Theravance Biopharma, Inc. (TBPH)

16.49 -0.13 (-0.78%) USD  |  NASDAQ  |  Apr 22, 15:30
More

Theravance Biopharma Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Integer Holdings Corp. Upgrade
QuidelOrtho Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Avalo Therapeutics, Inc. Upgrade